Evinacumab significantly lowers LDL C in kids with homozygous familial hypercholesterolemia Dr. Kamal Kant Kohli1 Jun 2022 10:00 AM ISTEvinacumab is a fully-human monoclonal antibody that binds to and blocks the function of angiopoietin-like 3 (ANGPTL3). According to findings from a...
FDA approves treprostinil dry powder inhaler for treatment of PAH Dr. Kamal Kant Kohli27 May 2022 10:15 AM ISTThe Food and Drug Administration (FDA) has granted approval to Tyvaso DPI (treprostinil) inhalation powder for treating pulmonary arterial...
FDA Approves tapinarof cream- first nonsteroidal treatment for plaque psoriasis Dr. Kamal Kant Kohli26 May 2022 10:00 AM ISTThe Food and Drugs Administration has approved Vtama cream for treating plaque psoriasis with varying severity. The approval was announced by...
Paclitaxel devices show no increased mortality compared to non-drug coated devices: SAFE-PAD study Dr. Kamal Kant Kohli23 May 2022 7:30 PM ISTOngoing long-term follow-up of Medicare patients who received paclitaxel-coated devices for the treatment of PAD continues to show no evidence of an...
FDA approves dupilumab as first Treatment for Eosinophilic Esophagitis Dr. Kamal Kant Kohli23 May 2022 9:15 AM ISTDupilumab (Dupixent, Regeneron Pharmaceuticals, Inc.) is first drug in the U.S. specifically indicated for the treatment of eosinophilic...
Changed policy for use of erythropoietin stimulating agents has lowered MACE in kidney failure patients Dr. Kamal Kant Kohli22 May 2022 7:30 PM ISTWashington, DC: A recent study published in CJASN has investigated how 2011 changes to anemia care have impacted clinical outcomes among patients with...
FDA authorizes wearable neuromodulation device for fibromyalgia Dr. Kamal Kant Kohli22 May 2022 7:30 PM ISTFood and Drug administration has authorized use of Quell® neuromodulation device as an aid in reducing the symptoms of fibromyalgia in adults with...
Abaloparatide Effective In Ignored Population: Men With Osteoporosis Dr. Nandita Mohan21 May 2022 9:30 AM ISTOsteoporosis is commonly known as a "silent disease" because it progresses without symptoms until afracture occurs. It develops less often in men than...
Dasiglucagon cuts IV glucose requirement in Pediatric Patients with Congenital Hyperinsulinism: Phase 3 Trial Dr. Kamal Kant Kohli20 May 2022 7:45 PM ISTreducing the requirement for IV glucose
Avacopan reduces ENT involvement and glucocorticoid use in ANCA-associated vasculitis: phase 3 ADVOCATE trial Dr. Kamal Kant Kohli19 May 2022 4:15 AM ISTSan Francisco, CA : Avacopan was better than prednisone in reducing respiratory as well as ear, nose and throat (ENT) involvement and enabled reduced...
FDA Limits Use of Janssen COVID-19 Vaccine to Certain Individuals Dr. Shravani Dali18 May 2022 7:45 PM ISTFDA Limits Use of Janssen COVID-19 Vaccine to Certain Individuals, according to a recent Coronavirus (COVID-19) Update published on May 5, 2022 ...
'Twincretin' Tirzepatide Recieves FDA Approval for Type 2 Diabetes Dr. Nandita Mohan18 May 2022 10:30 AM ISTThe "Twincretin" era for treating patients with type 2 diabetes has begun, with the US Food and Drug Administration's (FDA's) approval...
